|
Volumn 14, Issue 7 SUPPL. 4, 2000, Pages 15-19
|
Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METHODOLOGY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PREOPERATIVE CARE;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
SQUAMOUS CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASM STAGING;
PREOPERATIVE CARE;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0034218998
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (5)
|